Modified release

Modified release capabilities offer a number of advantages in drug delivery. In cases where a delayed or controlled release of the API from the dosage form is required, Ardena has a number of modified release technologies available to develop and GMP-produce monolithic or multi-particulate matrix-type and reservoir-type systems, including:

  • (coated) beads, granules or minitablets
  • matrix tablets